0001104659-23-000143.txt : 20230103
0001104659-23-000143.hdr.sgml : 20230103
20230103094506
ACCESSION NUMBER: 0001104659-23-000143
CONFORMED SUBMISSION TYPE: 3
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230101
FILED AS OF DATE: 20230103
DATE AS OF CHANGE: 20230103
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Cooper Joseph Patrick
CENTRAL INDEX KEY: 0001368711
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37846
FILM NUMBER: 23500600
MAIL ADDRESS:
STREET 1: PETER TSOFLIAS, C/O BLANK ROME LLP
STREET 2: ONE LOGAN SQUARE, FL 9
CITY: PHILADELPHIA
STATE: PA
ZIP: 19103
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Quoin Pharmaceuticals, Ltd.
CENTRAL INDEX KEY: 0001671502
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 000000000
STATE OF INCORPORATION: L3
BUSINESS ADDRESS:
STREET 1: 23 HATA'AS STREET
CITY: KFAR SABA
STATE: L3
ZIP: 44425
BUSINESS PHONE: 97299741444
MAIL ADDRESS:
STREET 1: 23 HATA'AS STREET
CITY: KFAR SABA
STATE: L3
ZIP: 44425
FORMER COMPANY:
FORMER CONFORMED NAME: Cellect Biotechnology Ltd.
DATE OF NAME CHANGE: 20160721
FORMER COMPANY:
FORMER CONFORMED NAME: Cellect Biomed Ltd.
DATE OF NAME CHANGE: 20160406
3
1
tm2233798-6_3seq1.xml
OWNERSHIP DOCUMENT
X0206
3
2023-01-01
0
0001671502
Quoin Pharmaceuticals, Ltd.
QNRX
0001368711
Cooper Joseph Patrick
AZRIELI CENTER, ROUND TOWER, 30TH FLOOR
132 MENACHEM BEGIN BLVD
TEL AVIV
L3
6701101
ISRAEL
1
0
0
0
Share Option (right to buy)
0.0035
2023-04-12
2032-04-12
Ordinary Shares
64285600
D
The option vests in four equal annual installments beginning on April 12, 2023.
The number of securities underlying the option and the exercise price are listed in terms of ordinary shares, with five thousand (5,000) ordinary shares of the Issuer
represented by one (1) American Depositary Share ("ADS"), which evidences the grant of an option to buy 12,857.12 ADSs at the exercise price of $17.50 per
ADS.
/s/ Joseph Cooper
2023-01-01